Protecting Innovation Advancing Safer Prescriptions
At Xact Laboratories, we believe pharmacogenomics should be the standard of care. That’s why we’ve invested in technology that not only delivers insights but also protects the pathways that make safer prescribing possible.
OUR PATENTS AT A GLANCE
U.S. Patent No. 12,354,724 B2
Issued: July 8, 2025
Title: Automated transmission of pharmacogenomic and genetic efficacy data into pharmacy and provider networks.
What It Means in Simple Terms: This patent protects our technology that securely moves genetic test results into the systems used by:
- Pharmacies
- Doctors
- Insurance companies (PBMs)
It makes sure those results are delivered:
- In the right format
- At the right time
- Into the right system
So that doctors and pharmacists can use them immediately when making medication decisions.
Why This Matters
Medication problems cost the U.S. over $500 billion per year, often because doctors don’t know how a patient will respond to a drug.
Our patented platform:
- Makes it possible to avoid trial-and-error prescribing
- Helps doctors choose the safest, most effective medication before it’s even picked up at the pharmacy
- Supports automated alerts inside the provider’s or pharmacy’s system — without needing to log into a separate portal
What This Protects
The process of transmitting genetic data across healthcare IT systems
- Clinical decision support tied to PGx results
- Interoperability of pharmacogenomic data within EMR, EHR, and pharmacy workflows
- Security, structure, and timing of this exchange